The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of serious Covid-19 infection.

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy.

Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with rival vaccine makers.